Omega Healthcare Investors (NYSE:OHI) Releases Quarterly Earnings Results

Omega Healthcare Investors (NYSE:OHIGet Free Report) announced its quarterly earnings results on Wednesday. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.33, Zacks reports. Omega Healthcare Investors had a net margin of 34.41% and a return on equity of 8.83%. Omega Healthcare Investors updated its FY 2025 guidance to 2.900-2.980 EPS.

Omega Healthcare Investors Trading Up 1.9 %

Shares of OHI traded up $0.73 during mid-day trading on Wednesday, reaching $38.33. The company had a trading volume of 2,807,746 shares, compared to its average volume of 1,855,654. The stock has a market cap of $10.35 billion, a price-to-earnings ratio of 28.18, a price-to-earnings-growth ratio of 1.08 and a beta of 0.99. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The firm has a fifty day simple moving average of $38.16 and a 200-day simple moving average of $39.08. Omega Healthcare Investors has a fifty-two week low of $27.74 and a fifty-two week high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th will be paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.99%. The ex-dividend date is Monday, February 10th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Wall Street Analyst Weigh In

OHI has been the topic of a number of analyst reports. Mizuho increased their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a report on Thursday, December 5th. Berenberg Bank started coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Royal Bank of Canada boosted their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research note on Thursday, October 31st. Finally, BMO Capital Markets raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective for the company in a research report on Monday, December 9th. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $41.67.

View Our Latest Stock Report on Omega Healthcare Investors

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

See Also

Earnings History for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.